No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Bone Marrow Cells / metabolism
-
Bone Marrow Cells / pathology*
-
Clonal Evolution
-
Exome
-
Homeodomain Proteins / genetics
-
Humans
-
Isocitrate Dehydrogenase / genetics
-
Leukemia, Myeloid, Acute / drug therapy
-
Leukemia, Myeloid, Acute / genetics*
-
Leukemia, Myeloid, Acute / pathology
-
Mutation*
-
Phosphoproteins / genetics
-
RNA Splicing Factors
-
Recurrence
-
Remission Induction
-
Repressor Proteins / genetics
-
Ribonucleoprotein, U2 Small Nuclear / genetics
-
Sequence Analysis, DNA
-
Time Factors
-
Zinc Finger E-box Binding Homeobox 2
-
fms-Like Tyrosine Kinase 3 / genetics
Substances
-
Antineoplastic Agents
-
Homeodomain Proteins
-
Phosphoproteins
-
RNA Splicing Factors
-
Repressor Proteins
-
Ribonucleoprotein, U2 Small Nuclear
-
SF3B1 protein, human
-
ZEB2 protein, human
-
Zinc Finger E-box Binding Homeobox 2
-
Isocitrate Dehydrogenase
-
IDH1 protein, human
-
FLT3 protein, human
-
fms-Like Tyrosine Kinase 3